What does COPHAREM do?

COPHAREM is a logistics company in Sint-Jans-Molenbeek. Private Limited, started on 22 March 1989, 1 establishment.

What is the address of COPHAREM?

The registered office of COPHAREM is located at de Ribaucourtstraat 5, 1080 Sint-Jans-Molenbeek.

Is COPHAREM still active?

Yes. According to the CBE (16 September 2026) COPHAREM is active, legal situation “Normale toestand”, started on 22 March 1989.

Is COPHAREM registered on Peppol?

Yes, COPHAREM is registered on the Peppol network with ID 0208:0437038943.

What is the enterprise number of COPHAREM?

The enterprise number of COPHAREM is BE0437038943.

When was COPHAREM founded?

COPHAREM was founded on 22 March 1989.

Is COPHAREM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 March 1989; 4 annual accounts filed, latest fiscal year 2024.

How much profit did COPHAREM make in 2024?

COPHAREM posted a profit after taxes of € 39,413 in financial year 2024.

What is the revenue of COPHAREM?

In its most recent annual accounts (2024), COPHAREM reported revenue of € 1,710,729.

How much does an employee at COPHAREM earn?

The average wage cost per full-time employee at COPHAREM was € 0 in 2024: staff costs of € 248,720 for 50,000 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does COPHAREM have?

According to the 2024 annual accounts, COPHAREM has 50,000 full-time equivalents (FTE).

COPHAREM (Private Limited) - Sint-Jans-Molenbeek

Dossier COPHAREM, printed on 16 September 2026 from databakkes.be/en/0437038943/copharem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

COPHAREM from Sint-Jans-Molenbeek, company number BE0437038943, closed financial year 2024 with a result of € 39,413 after tax. For that financial year COPHAREM recorded revenue of € 1.7 million and equity of € 626,912. Compared with financial year 2023, the result moved from € 70,996 to € 39,413. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2025.

What it is worth Growing

€ 626,912

▲ 7% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 39,413

▼ 44% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 133,560

▼ 56% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 608,320.

People and assets in 2024

Full-time equivalents

50,000

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 248,720

▲ 66% vs 2023

€ 0 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 11,567

▼ 36% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 65,854

▼ 53% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 422,980

▲ 19% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 127,964

▲ 21% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 1,677,123 Revenue 2021: € 1,677,123 First fiscal year in the series	€ 1,754,456 Revenue 2022: € 1,754,456 ▲ 5% vs 2021 (€ 1,677,123) Favourable step	€ 1,917,186 Revenue 2023: € 1,917,186 ▲ 9% vs 2022 (€ 1,754,456) Favourable step	€ 1,710,729 Revenue 2024: € 1,710,729 ▼ 11% vs 2023 (€ 1,917,186) Unfavourable step	▼ 11%
Gross margin	€ 255,579 Gross margin 2021: € 255,579 First fiscal year in the series	€ 385,205 Gross margin 2022: € 385,205 ▲ 51% vs 2021 (€ 255,579) Favourable step	€ 286,167 Gross margin 2023: € 286,167 ▼ 26% vs 2022 (€ 385,205) Unfavourable step	€ 352,735 Gross margin 2024: € 352,735 ▲ 23% vs 2023 (€ 286,167) Favourable step	▲ 23%
Profit after taxes	€ 53,257 Profit after taxes 2021: € 53,257 First fiscal year in the series	€ 170,512 Profit after taxes 2022: € 170,512 ▲ 220% vs 2021 (€ 53,257) Favourable step	€ 70,996 Profit after taxes 2023: € 70,996 ▼ 58% vs 2022 (€ 170,512) Unfavourable step	€ 39,413 Profit after taxes 2024: € 39,413 ▼ 44% vs 2023 (€ 70,996) Unfavourable step	▼ 44%
Equity	€ 542,678 Equity 2021: € 542,678 First fiscal year in the series	€ 516,503 Equity 2022: € 516,503 ▼ 5% vs 2021 (€ 542,678) Unfavourable step	€ 587,499 Equity 2023: € 587,499 ▲ 14% vs 2022 (€ 516,503) Favourable step	€ 626,912 Equity 2024: € 626,912 ▲ 7% vs 2023 (€ 587,499) Favourable step	▲ 7%
Total debts	€ 576,751 Total debts 2021: € 576,751 First fiscal year in the series	€ 481,477 Total debts 2022: € 481,477 ▼ 17% vs 2021 (€ 576,751) Favourable step	€ 599,210 Total debts 2023: € 599,210 ▲ 24% vs 2022 (€ 481,477) Unfavourable step	€ 616,798 Total debts 2024: € 616,798 ▲ 3% vs 2023 (€ 599,210) Unfavourable step	▲ 3%
Cash	€ 168,900 Cash 2021: € 168,900 First fiscal year in the series	€ 153,766 Cash 2022: € 153,766 ▼ 9% vs 2021 (€ 168,900) Unfavourable step	€ 304,786 Cash 2023: € 304,786 ▲ 98% vs 2022 (€ 153,766) Favourable step	€ 133,560 Cash 2024: € 133,560 ▼ 56% vs 2023 (€ 304,786) Unfavourable step	▼ 56%
Land & buildings	€ 5,749 Land & buildings 2021: € 5,749 First fiscal year in the series	€ 3,443 Land & buildings 2022: € 3,443 ▼ 40% vs 2021 (€ 5,749) Unchanged	€ 1,983 Land & buildings 2023: € 1,983 ▼ 42% vs 2022 (€ 3,443) Unchanged	€ 1,983 Land & buildings 2024: € 1,983 Unchanged (€ 1,983) Unchanged
Retained profit	€ 524,086 Retained profit 2021: € 524,086 First fiscal year in the series	€ 497,910 Retained profit 2022: € 497,910 ▼ 5% vs 2021 (€ 524,086) Unfavourable step	€ 568,907 Retained profit 2023: € 568,907 ▲ 14% vs 2022 (€ 497,910) Favourable step	€ 608,320 Retained profit 2024: € 608,320 ▲ 7% vs 2023 (€ 568,907) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 196,687 Dividend 2022: € 196,687 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 196,687) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 119,546 Bank debt 2021: € 119,546 First fiscal year in the series	€ 83,595 Bank debt 2022: € 83,595 ▼ 30% vs 2021 (€ 119,546) Favourable step	€ 139,032 Bank debt 2023: € 139,032 ▲ 66% vs 2022 (€ 83,595) Unfavourable step	€ 65,854 Bank debt 2024: € 65,854 ▼ 53% vs 2023 (€ 139,032) Favourable step	▼ 53%
Balance sheet total	€ 1,119,429 Balance sheet total 2021: € 1,119,429 First fiscal year in the series	€ 997,980 Balance sheet total 2022: € 997,980 ▼ 11% vs 2021 (€ 1,119,429) Unchanged	€ 1,186,708 Balance sheet total 2023: € 1,186,708 ▲ 19% vs 2022 (€ 997,980) Unchanged	€ 1,243,710 Balance sheet total 2024: € 1,243,710 ▲ 5% vs 2023 (€ 1,186,708) Unchanged	▲ 5%
Employees (FTE)	-	-	-	50,000 Employees (FTE) 2024: 50,000 First fiscal year in the series

Key figures of COPHAREM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to COPHAREM?

What happened at COPHAREM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2025 New annual accounts for financial year 2024: profit of € 39,413 (▼ 44% vs 2023). Source: NBB ↗
Apr 13, 1989 New establishment in Sint-Jans-Molenbeek. KBO
Mar 22, 1989 Start of the company according to the CBE. KBO

In short

From € 53,257 profit in 2021 to € 39,413 profit in 2024.

Paid € 144,245 in corporate taxes since 2021.

Best year ever: 2022, with € 170,512 profit.

On average € 0 of value added per employee in 2024.

Original PDFs at the National Bank ↗

A new publication or filing at COPHAREM? We notify you, reason included.

Follow COPHAREM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

de Ribaucourtstraat 5

1080 Sint-Jans-Molenbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CHIFAENIL

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0437.038.943

VAT number

BE 0437.038.943

Registered office

de Ribaucourtstraat 5, 1080 Sint-Jans-Molenbeek

Names & denominations

COPHAREM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 March 1989

Peppol

Active · Active since 30 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗